节点文献

Effects of raloxifene hydrochloride on bone mineral density,bone metabolism and serum lipids in postmenopausal women:a randomized clinical trial in Beijing

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 郑淑蓉吴宜勇张忠兰杨欣惠英张颖陈淑玲邓文慧刘慧Abie EkangakiJodie StocksKristine Harper刘建立

【Author】 ZHENG Shurong,WU Yiyong,ZHANG Zhonglan,YANG Xin,HUI Ying ZHANG Ying,CHEN Shuling,DENG Wenhui ,LIU Hui,Abie Ekangaki Jodie Stocks,Kristine Harper and LIU Jianli Department of Obstetrics and Gynaecology,Peking University First Hospital,Beijing 100034,China (Zheng SR,Yang X and Chen SL) Department of Obstetrics and Gynaecology,Beijing Hospital,Beijing 100730,China (Wu YY,Hui Y and Deng WH) Department of Obstetrics and Gynaecology,General Hospital of the PLA,Beijing 100853,China (Zhang ZL,Zhang Y,Liu H and Liu JL) Eli Lilly & Company,Indianapolis,Indiana,USA (Ekangaki A,Stocks J and Harper K)

【机构】 Department of Obstetrics and GynaecologyPeking University First HospitalBeijing HospitalGeneral Hospital of the PLAEli Lilly & CompanyIndianapolisGeneral Hospital of the PLA Beijing 100034ChinaBeijing 100730Beijing 100853Beijing 100034IndianaUSAChina

【Abstract】 Objective To determine the effects of raloxifene hydrochloride (RLX) on bone mineral density (BMD),bone metabolism markers and serum lipids in healthy postmenopausal women in Beijing.Methods A multicenter,randomized,double-blind,placebo-controlled study was conducted in a total of 204 healthy postmenopausal women (age 59.5±5.0 years and weight 62.8±8.7 kg) treated with either RLX 60 mg (n=102) or placebo (n=102) daily for 12 months. BMD,serum lipids,and bone markers were measured before and after drug administration.Results Compared with placebo,RLX produced a significant increase in both total lumbar spine and total hip BMD. For the lumbar spine,percentage increase in total BMD was 2.3% with RLX compared with a decrease of 0.1% with placebo ( P <0.001). Corresponding values for total hip BMD were a 2.5% increase for RLX and a 1.1% increase for placebo ( P =0.011). For biochemical markers of bone metabolism,serum osteocalcin and C-telopeptide,percentage decreases were 27.65% and 24.02% in RLX-treated subjects. Corresponding values in placebo were a 10.64% decrease and a 15.75% increase (RLX compared with placebo,both P <0.001). For total cholesterol and low-density lipoprotein cholesterol levels,percentage decreases were 6.44% and 34.58% in the RLX-treated group. Corresponding values in placebo-treated patients were a 1.44% increase and a 19.07% decrease (RLX compared with placebo,both P <0.001). No differences were found for high-density lipoprotein cholesterol or triglyceride levels between the two groups. Only 5 subjects discontinued early owing to an adverse event (3 in the RLX group and 2 in the placebo group). Conclusions This study confirms that RLX exerts positive effects on the skeleton,increasing BMD and decreasing biochemical markers of bone metabolism,and has a positive effect on the overall serum lipid profile in postmenopausal women in China.

  • 【文献出处】 Chinese Medical Journal ,中华医学杂志(英文版) , 编辑部邮箱 ,2003年08期
  • 【分类号】R711.75
  • 【下载频次】19
节点文献中: 

本文链接的文献网络图示:

本文的引文网络